Article Text

Download PDFPDF

  1. Wisia Wedzicha, Editor-in-Chief

    Statistics from


    It is well known that β blockers reduce mortality in patients with cardiovascular disease. COPD is often complicated by cardiovascular disease and patients are often not treated with β blockers due to concern over possible worsening of airways obstruction, even though cardioselective β blockers have little deleterious effect on airway function. In this issue, Dransfield and colleagues report a study of patients with COPD hospitalised with an exacerbation. The authors show, after correcting for relevant confounders, that COPD patients treated with β blockers have a lower in-patient mortality, than those patients not …

    View Full Text

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles